Translational Research on Infection, Inflammation, and Innate Immunity
The Fraunhofer Innovation Platform for Drug Discovery and Delivery at the Hebrew University in Jerusalem, Israel, (FIP_DD@HUJI) is a joint research institution of Fraunhofer IGB and the Institute for Drug Research of the Hebrew University. The focus of the Innovation Platform is on discovery and validation of new antiinfective and anti-inflammatory compounds as well as targeted nanoparticle based delivery systems for virual infections and autoimmune diseases.
The FIP_DD@HUJI is the continuation of the joint project "JRHDD – Joint Research Hub for Drug Discovery and Delivery". It started in October 2018 and will initially be funded for a period of three years. The Innovation Platform is jointly headed by Prof. Dr. Steffen Rupp (Fraunhofer IGB) and Prof. Dr. Gershon Golomb (HUJI).